| pubmed-article:17872455 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17872455 | lifeskim:mentions | umls-concept:C0023821 | lld:lifeskim |
| pubmed-article:17872455 | lifeskim:mentions | umls-concept:C2717940 | lld:lifeskim |
| pubmed-article:17872455 | lifeskim:mentions | umls-concept:C0085201 | lld:lifeskim |
| pubmed-article:17872455 | lifeskim:mentions | umls-concept:C0728940 | lld:lifeskim |
| pubmed-article:17872455 | lifeskim:mentions | umls-concept:C0071097 | lld:lifeskim |
| pubmed-article:17872455 | lifeskim:mentions | umls-concept:C0015252 | lld:lifeskim |
| pubmed-article:17872455 | lifeskim:mentions | umls-concept:C0033268 | lld:lifeskim |
| pubmed-article:17872455 | lifeskim:mentions | umls-concept:C1314939 | lld:lifeskim |
| pubmed-article:17872455 | lifeskim:mentions | umls-concept:C0392760 | lld:lifeskim |
| pubmed-article:17872455 | pubmed:issue | 11 | lld:pubmed |
| pubmed-article:17872455 | pubmed:dateCreated | 2007-10-18 | lld:pubmed |
| pubmed-article:17872455 | pubmed:abstractText | Pioglitazone, an antihyperglycemic drug, increases plasma high-density lipoprotein (HDL)-cholesterol in patients with type 2 diabetes. The mechanisms by which pioglitazone regulate HDL levels are not clear. This study examined the effect of pioglitazone on hepatocyte apolipoprotein AI (apoA-I) and apoA-II production and HDL-protein/cholesterol ester uptake. | lld:pubmed |
| pubmed-article:17872455 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17872455 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17872455 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17872455 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17872455 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17872455 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17872455 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17872455 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17872455 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17872455 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17872455 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17872455 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:17872455 | pubmed:issn | 1524-4636 | lld:pubmed |
| pubmed-article:17872455 | pubmed:author | pubmed-author:KashyapMoti... | lld:pubmed |
| pubmed-article:17872455 | pubmed:author | pubmed-author:QinShucunS | lld:pubmed |
| pubmed-article:17872455 | pubmed:author | pubmed-author:KamannaVaijin... | lld:pubmed |
| pubmed-article:17872455 | pubmed:author | pubmed-author:LiuTianjiaoT | lld:pubmed |
| pubmed-article:17872455 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:17872455 | pubmed:volume | 27 | lld:pubmed |
| pubmed-article:17872455 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17872455 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17872455 | pubmed:pagination | 2428-34 | lld:pubmed |
| pubmed-article:17872455 | pubmed:meshHeading | pubmed-meshheading:17872455... | lld:pubmed |
| pubmed-article:17872455 | pubmed:meshHeading | pubmed-meshheading:17872455... | lld:pubmed |
| pubmed-article:17872455 | pubmed:meshHeading | pubmed-meshheading:17872455... | lld:pubmed |
| pubmed-article:17872455 | pubmed:meshHeading | pubmed-meshheading:17872455... | lld:pubmed |
| pubmed-article:17872455 | pubmed:meshHeading | pubmed-meshheading:17872455... | lld:pubmed |
| pubmed-article:17872455 | pubmed:meshHeading | pubmed-meshheading:17872455... | lld:pubmed |
| pubmed-article:17872455 | pubmed:meshHeading | pubmed-meshheading:17872455... | lld:pubmed |
| pubmed-article:17872455 | pubmed:meshHeading | pubmed-meshheading:17872455... | lld:pubmed |
| pubmed-article:17872455 | pubmed:meshHeading | pubmed-meshheading:17872455... | lld:pubmed |
| pubmed-article:17872455 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17872455 | pubmed:articleTitle | Pioglitazone stimulates apolipoprotein A-I production without affecting HDL removal in HepG2 cells: involvement of PPAR-alpha. | lld:pubmed |
| pubmed-article:17872455 | pubmed:affiliation | Atherosclerosis Research Center, Department of Veterans Affairs Healthcare System, Long Beach, California 90822, USA. | lld:pubmed |
| pubmed-article:17872455 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17872455 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17872455 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17872455 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17872455 | lld:pubmed |
